Objective: To perform a systematic review to evaluate the quality of warfarin anticoagulation
control in outpatient pharmacist-managed anticoagulation services (PMAS) compared with …

Objectives: We performed this systematic review and meta-analysis to confirm whether
patients benefit more from pharmacist-led anticoagulation management than other models …

America (19% versus 22%–36%), more from Eastern and fewer from Western Europe (53%
versus 40%–48% in total), and a different percentage from Latin America (13% versus 6 …

Aims Non-vitamin K antagonist oral anticoagulants (NOACs) were in pivotal randomised
controlled trials at least non-inferior to warfarin for stroke prevention in atrial fibrillation, but …

Anticoagulation control has been associated with risk of thromboembolism and hemorrhage.
Herein, we explore the relationship between anticoagulation control achieved in left …

Anticoagulation with warfarin has been used for over 60 years; however, its administration is
fraught with difficulty since many factors can affect warfarin dosing. The concept of time in …

The Salford Lung Study (SLS) of patients with asthma and chronic obstructive pulmonary
disease (COPD) is a practical, community-based, randomized, open-label pragmatic study …

BACKGROUND: Warfarin is a common treatment option to manage patients with
nonvalvular atrial fibrillation (NVAF) in clinical practice. Understanding current pharmacist …

Background: Oral anticoagulation therapy with vitamin K antagonists (VKA) such as warfarin
and acenocoumarol is recommended in patients with atrial fibrillation (AF) and risk factors …

Warfarin prevents stroke and prolongs survival in patients with atrial fibrillation and flutter
(AF, collectively) but can cause hemorrhage. The time in international normalized ratio (INR) …